Post Deleted
…………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. ……………………..
…………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. ……………………..
Career Resources
Not to hijack post, but has anyone watched and recommend Shkreli's yt analysis of biotech/pharma companies?
Gotta be honest DCFs in healthcare are used very infrequently. Why would you use a perpetuity formula when the cash flows will significantly change once the patent expires and the market floods with generics?
What method is typically used to value companies in healthcare?
Why are you looking for FV and not PV?
Amet enim nihil tenetur est. Aliquam sunt hic adipisci consequatur. Esse accusantium nesciunt illo molestiae odit perferendis libero et.
Autem et aliquam tempora voluptas officiis. Veniam reiciendis officia sit non dolorum sint. Neque mollitia perferendis qui neque sunt recusandae.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...